![[IPWatchdog Logo]](https://ipwatchdog.com/wp-content/themes/IPWatchdog%20-%202023/assets/images/temp/logo-small@2x.png){kind=logo}
Keith Fredlake
Member
Cozen O'Connor
Keith Fredlake is a registered patent attorney at Cozen O’Connor. His practice includes drafting and prosecuting patent applications; working with clients on design patents; and counseling clients on issues regarding the patentability of inventions, patent rights in foreign countries, and the infringement and validity of U.S. patents. He also regularly performs portfolio review for clients, including freedom-to-operate, invalidity, patentability, and opposition searches. Keith is also experienced in the preparation of invalidity and non-infringement options for utility and design patents.
In addition, he has significant experience in conducting trademark clearances, registering trademarks, negotiations and licensing, and adversarial proceedings before the U.S. Trademark and Appeal Board and Internet Corporation for Assigned Names and Numbers.
Keith’s clients are primarily in the chemical and life sciences industry, including chemistry, chemical engineering, oil and gas-petrochemicals, medical devices, and pharmaceuticals.
He was recommended by Legal 500 US in 2015 for Patent Prosecution.
Recent Articles by Keith Fredlake
Although what qualifies as art under the AIA can be distilled to disclosures before a patent application, both pre-AIA and AIA created exceptions for intervening disclosures in Section 102(a)(2). Intervening disclosures are defined by an earlier filing date, but a later publication date and are sometimes referred to as secret prior art. Intervening disclosures apply only to US patents, US publications, and PCT applications. Other types of disclosures, such as disclosures at a Beijing conference in Chinese would need to be considered under Section 102(a)(1). Where is this expansion for intervening disclosures going to come from? Mainly from two primary sources: 1) US patents or publications that have foreign priority claims; and 2) PCT applications published in a language other than English, regardless of foreign priority claim… The potential doubling of available intervening disclosures would create significantly more prior art.
